The Canadian Lung Association/Canadian Thoracic Society and tuberculosis prevention and control

Canadian Respiratory Journal

Volumn 14, Issue 7, 2007, Pages 427-431

  Long, Richard ^a,b  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b Aberhart Hospital   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; CANADA; HEALTH ECONOMICS; HEALTH INSURANCE; HEALTH SERVICE; HUMAN; IMMIGRATION; INCIDENCE; INFORMATION DISSEMINATION; LUNG TUBERCULOSIS; MEDICAL SOCIETY; MORTALITY; PRIORITY JOURNAL; REHABILITATION CARE; TUBERCULOSIS CONTROL;

EID: 36749039275     PISSN: 11982241     EISSN: None     Source Type: Journal    
DOI: 10.1155/2007/612974     Document Type: Article

References (34)

1. Wherrett GJ. The miracle of the empty beds: A history of tuberculosis in Canada. Buffalo: University of Toronto Press, 1977.
2. Dubos R, Dubos J. The White Plague: Tuberculosis, Man, and Society. Boston: Little, Brown, 1952.
3. Bryder L. Below the Magic Mountain: A Social History of Tuberculosis in Twentieth-Century Britain. Oxford: Oxford University Press, 1988.
4. McCuaig K. The Weariness, the Fever, and the Fret. The Campaign against Tuberculosis in Canada, 1900-1950. Montreal: McGill-Queen's University Press, 1999.
5. Murray JF. Bill Dock and the location of pulmonary tuberculosis: How bed rest might have helped consumption. Am J Respir Crit Care Med 2003;168:1029-33.
6. Houston CS. RG Ferguson: Crusader against tuberculosis. Toronto: Dundurn Press Limited, 1991.
7. Grzybowski S. Epidemiology of tuberculosis and the role of BCG. Clin Chest Med 1980;1:175-87.
8. Hopkins JW. BCG vaccination in Montreal. Am Rev Tuberc 1941;43:581-99.
9. Ferguson RG, Simes AB. BCG vaccination of Indian infants in Saskatchewan. Tubercle 1949;30:5-11.
10. Behr MA, Wilson MA, Gill WP, et al. Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 1999;284:1520-3.
11. Springett VH. Ten-year results during the introduction of chemotherapy for tuberculosis. Tubercle 1971;52:73-87.
12. Pugsley HE, Allen EA, Cheung OT, Coulthard HS, Gale GL. Results of the treatment of tuberculosis before and since the introduction of chemotherapy. Can Med Assoc J 1960;83:424-9.
13. Ryan F. The Forgotten Plague: How the Battle Against Tuberculosis was Won - and Lost. Boston: Little, Brown, 1992.
14. McDermott W, Muschenheim C, Hadley SJ, Hull-Smith H, Tracy A. Streptomycin in the treatment of tuberculosis in humans. Ann Intern Med 1947;27:769-822.
15. Allen EA, Stewart M, Jeney P. The efficiency of post-sanatorium management of tuberculosis. A study of one thousand tuberculous patients discharged from sanatoria in Ontario. Can J Public Health 1964;55:323-33.
16. Keers RY. Pulmonary tuberculosis: A journey down the centuries. London: Baillière Tindall, 1978.
17. Werhane MJ, Snukst-Torbeck G, Schraufnagel DE. The tuberculosis clinic. Chest 1989;96:815-8.
18. Long R, Chui L, Kakulphimp J, Zielinski M, Talbot J, Kunimoto D. Postsanatorium pattern of antituberculous drug resistance in the Canadian-born population of western Canada: Effect of outpatient care and immigration. Am J Epidemiol 2001;153:903-11.
19. Khan K, Campbell A, Wallington T, Gardam M. The impact of physician training and experience on the survival of patients with tuberculosis. CMAJ 2006;175:749-53.
20. Grzybowski S, Enarson D. [Results in pulmonary tuberculosis patients under various treatment program conditions.] Bull Int Union Tuberc 1978;53:70-5.
21. Enarson DA. Principles of IUATLD collaborative tuberculosis programmes. Bull Int Union Tuberc Lung Dis 1991;66:195-200.
22. Anti-tuberculosis drug resistance in the world: Third global report. Geneva: World Health Organization, 2004. (Version current at September 6, 2007).
23. The Canadian Lung Association/Canadian Thoracic Society and Tuberculosis Prevention and Control, 2007. The Canadian Tuberculosis Standards, 6th Edition. . (In press)
24. The Arden House Conference on Tuberculosis. U.S. Department of Health, Education, and Welfare. Public Health Service No. 784. Washington, District of Columbia: U.S. Government Printing Office, 1961.
25. Jereb J, Albalak R, Castro KG. The Arden House Conference on Tuberculosis, revisited: Perspectives for tuberculosis elimination in the United States. Semin Respir Crit Care Med 2004;25:255-69.
26. Brudney K, Dobkin J. Resurgent tuberculosis in New York City. Human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis 1991;144:745-9.
27. Frieden TR, Fujiwara PI, Washko RM, Hamburg MA. Tuberculosis in New York City - turning the tide. N Engl J Med 1995;333:229-33.
28. Benatar SR. Prospects for global health: Lessons from tuberculosis. Thorax 1995;50:487-9.
29. Jones DS. The health care experiments at Many Farms: The Navajo, tuberculosis, and the limits of modern medicine, 1952-1962. Bull Hist Med 2002;76:749-90.
30. Yip D, Bhargava R, Yao Y, Sutherland K, Manfreda J, Long R. Pediatric tuberculosis in Alberta. Epidemiology and case characteristics (1990-2004). Can J Public Health 2007;98:276-80.
31. Kochi A. Tuberculosis: A Global Emergency. Geneva: World Health Organization, 1994.
32. Benatar SR. Respiratory health in a globalizing world. Am J Respir Crit Care Med 2001;163:1064-7.
33. Statistics Canada. Census of Population: Immigrant population by place of birth and period of immigration. (Version current at September 10, 2007).
34. Smith R. The Champagne glass of world poverty. BMJ 1999;318. (Edit)